Interestingly, the analysis of the dissected GBM xenografts confirmed that Tau is expressed in a high percentage of tumor cells (co-stained with a GFAP antibody) in the Tau-high PDX, whereas there is very little expression in the Tau-low PDX (Figure 2E). The gene discussed is MAPT; the disease is glioblastoma.